The Arroven Study (Ma25101): Post-Authorisation Observational Safety Study of Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma
Ayto, R d'Amore, F Moestl, M Chau, I Paneesha, S Kinley, J Huebner, D Porter, J Exter, B
Ayto, R
d'Amore, F
Moestl, M
Chau, I
Paneesha, S
Kinley, J
Huebner, D
Porter, J
Exter, B
Citations
Altmetric:
Abstract
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings